Zedelmayer Christine 4
4 · Equillium, Inc. · Filed Mar 11, 2026
Research Summary
AI-generated summary of this filing
Equillium (EQ) COO Christine Zedelmayer Exercises Options, Sells Shares
What Happened
- Christine Zedelmayer, Senior Vice President and COO of Equillium (EQ), exercised a total of 152,361 option shares on March 9, 2026 (three exercises at $0.79 each, aggregate cost $119,604) and sold 181,219 common shares in open-market transactions the same day for approximately $362,438 (weighted avg price $2.00). The filing also shows corresponding derivative disposals at $0.00 reflecting the conversion/retirement of the exercised option instruments.
Key Details
- Transaction date: March 9, 2026; Form 4 filed March 11, 2026 (timely).
- Options exercised: 35,695 + 41,666 + 75,000 = 152,361 shares at $0.79; total cash paid ≈ $119,604.
- Open-market sale: 181,219 shares, weighted average price $2.00 (sales executed between $2.00 and $2.015 per share); total proceeds ≈ $362,438.
- Footnote F1: Sales were made under a Rule 10b5-1 trading plan adopted Aug 27, 2025.
- Footnote F2: Price shown is weighted average; trades occurred at $2.00–$2.015.
- Footnote F3: The option vesting schedule: 25% after one year, then monthly over 3 years (applies to the option grant).
- Shares owned after the transaction: not disclosed in the supplied filing details.
Context
- This was an option exercise followed by an immediate open-market sale of shares (consistent with a cashless or sell-to-cover pattern). The sale was executed under a pre-established 10b5-1 plan, which indicates the trades were pre-planned rather than ad-hoc. The filing is factual and does not indicate insider intent.
Insider Transaction Report
Form 4
Zedelmayer Christine
Sr. Vice President and COO
Transactions
- Exercise/Conversion
Common Stock
2026-03-09$0.79/sh+35,695$28,021→ 127,139 total - Exercise/Conversion
Common Stock
2026-03-09$0.79/sh+41,666$32,708→ 168,805 total - Exercise/Conversion
Common Stock
2026-03-09$0.79/sh+75,000$58,875→ 243,805 total - Sale
Common Stock
[F1][F2]2026-03-09$2.00/sh−181,219$362,438→ 62,586 total - Exercise/Conversion
Employee Stock Option (right to buy)
[F3]2026-03-09−35,695→ 0 totalExercise: $0.79Exp: 2028-09-12→ Common Stock (35,695 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
[F3]2026-03-09−41,666→ 0 totalExercise: $0.79Exp: 2029-02-12→ Common Stock (41,666 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
[F3]2026-03-09−75,000→ 0 totalExercise: $0.79Exp: 2029-12-09→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.015, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
Signature
/s/ Christine Zedelmayer|2026-03-10